News

Endo Unveils Innovative Simulator for Urologists to Combat Peyronie's Disease

Endo Unveils Innovative Simulator for Urologists to Combat Peyronie's Disease

Introducing Endo's New Spatial Computing Injection Simulator

Endo, Inc. (OTCQX: NDOI) is set to revolutionize urology training with the launch of its Spatial Computing Injection Simulator, specifically designed to assist in the treatment of Peyronie's disease. This innovative simulator integrates physical models with digital technology, allowing urology specialists to improve their injection techniques in an engaging and effective manner.

An Immersive Learning Experience for Urology Specialists

Healthcare providers often benefit from hands-on learning experiences. Endo's simulator provides a unique blend of reality by combining a physical penile model and a digital interface using the advanced Apple Vision Pro app. This training tool will be showcased at a major medical event, as Endo aims to provide specialists with the skills required to effectively administer treatments for Peyronie's disease.

What is Peyronie's Disease?

Peyronie's disease (PD) is characterized by the development of fibrous scar tissue inside the penis, leading to a curved and often painful erection. Nearly 1 in 10 men may experience this condition, but many feel embarrassed to seek help due to stigma. Endo's new simulator aims to address these challenges by empowering specialists with better techniques for administering treatments like XIAFLEX, the only FDA-approved nonsurgical remedy for PD.

Enhancing Patient Care Through Innovation

Justin Mattice, Senior Vice President & General Manager at Endo, expressed the belief that the Spatial Computing Injection Simulator can profoundly impact patient care. By providing users with hands-on practice alongside comprehensive video demonstrations and practical information, Endo is committed to refining the skills of those who treat this sensitive condition. The 20-minute immersive simulator experience not only allows urologists to practice injection techniques but also helps them understand the post-injection care process.

Collaboration for Advanced Technology

Endo collaborated with Lucid Dream, a technology agency specializing in innovative solutions, to develop the Apple Vision Pro app. This partnership leverages cutting-edge technology to create a more interactive and effective training environment for urologists, ultimately benefiting patients who rely on these treatments.

Understanding the Risks Associated with XIAFLEX

It is crucial for healthcare providers to recognize the potential risks of administering XIAFLEX. This treatment, while effective, is not suitable for everyone. Individuals who have previously experienced allergic reactions to collagenase clostridium histolyticum or who have specific anatomical challenges should not use it. Understanding the risks also includes awareness of possible severe side effects, including penile fractures, bruising, and allergic reactions.

Additionally, patients are reminded to refrain from sexual activity between treatment injections and to avoid certain physical strains during the recovery period. These precautionary measures help ensure the optimal effectiveness of the treatment and patient safety.

Commitment to Healthcare and Patient Education

Endo, Inc. is dedicated to advancing the quality of care in urology and empowering healthcare providers with innovative tools and educational resources. The launch of the Spatial Computing Injection Simulator is a critical step in enhancing how treatments for Peyronie's disease are taught and administered. By enabling urologists to develop their skills in a low-pressure environment, Endo fosters a culture of continuous learning and improvement.

About Endo

Endo is a diversified specialty pharmaceutical company focused on developing solutions that improve patient outcomes. The organization prides itself on a passionate team dedicated to transforming innovative insights into effective therapies aimed at enhancing patients' lives.

Frequently Asked Questions

What is the Spatial Computing Injection Simulator?

The Spatial Computing Injection Simulator is an innovative tool developed by Endo for urology specialists to improve their injection techniques for Peyronie's disease.

How does the simulator enhance urology training?

The simulator combines hands-on practice with digital technology, allowing users to refine their techniques in a realistic but controlled environment.

Why is Peyronie's disease often underdiagnosed?

Many men may feel uncomfortable discussing Peyronie's disease, leading to low diagnosis rates despite its relatively common occurrence.

What precautions should be taken when using XIAFLEX?

Patients should avoid using XIAFLEX if they have a history of allergic reactions to its components and refrain from sexual activity during treatment.

Who developed the Apple Vision Pro app for Endo's simulator?

Endo partnered with Lucid Dream, a technology agency, to create the Apple Vision Pro app, enhancing the simulator's immersive experience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rockford Fosgate Elevates Marketing Maverick to Lead Role

Updated Category News Views 87

Changing the Guard in High-Performance Audio Marketing Out of Arizona, we get a shake-up that feels like a no-brainer for anyone in the high-performance audio market. Rockford Fosgate decided to elevate Tammy Lowe to the Vice President of Marketing role, effective immediately. With nearly four decades under her belt at the sunny Tempe-based HQ, it's hard to argue with the...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 30

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading
Anguilla: Paradise for Safe, Solo Beach Escapes

Updated Category News Views 31

A Safe Haven for Solo Adventurers You ever dream of escaping to a place where the world slows down and serenity reigns supreme? Somewhere you can kick back, soak up the sun, listen to the waves, and leave your worries behind? Well, folks, Tranquility Beach Anguilla fits that bill and then some. Why Anguilla Tops the List Let's talk about the accolades Anguilla has raked...

Continue Reading
FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 75

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading
Food Emulsifiers Surge: Market to Hit $5.60B by 2031

Updated Category News Views 72

Forecasting Growth in Food Emulsifiers Picture this: the food emulsifiers market is steaming ahead, anticipating a thunderous boom from $4.43 billion in 2026 to a whopping $5.60 billion by 2031. According to recent estimates, that's a steady clip at a CAGR of 4.8%. If you're thinking that's just more industry chatter, let's peel back the layers and see what makes this...

Continue Reading
SOTERIA Launches Cancer Hunt™ for Military Patients

Updated Category News Views 66

Breaking the Barriers for Our Military's Cancer Fight Diving into the world of precision medicine, SOTERIA Precision Medicine Foundation has sparked a revolution with Cancer Hunt™. It's staggering to think about the piles of bureaucracy and insurance red tape that often stand between cancer patients and life-saving care. Especially when those patients are veterans or...

Continue Reading
Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

Updated Category News Views 119

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Continue Reading
Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

Updated Category News Views 0

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

Continue Reading
Triskell's 2026 Update: AI Leverages Portfolio Data

Updated Category News Views 33

Triskell's Strategic AI Leap Forward Forget the old grind of manual data tinkering—Triskell Software's latest AI enhancements in their 2026 SP2 release are setting a new stage. The Spain-based outfit is tweaking their Project Portfolio Management tools under the hood to suit modern instincts. It seems like portfolio management is getting a brain boost with some added AI...

Continue Reading
Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Updated Category News Views 45

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Continue Reading

Top 5 Most Recently Viewed Articles

Ionpath Introduces MIBIslide™ Blue for Enhanced Imaging

Updated Category News Views 174

Innovative Advances in Multi-Omics Imaging Ionpath, a leading name in high-definition spatial proteomics, has recently launched its newest product, the MIBIslide™ Blue. This groundbreaking technology marks a significant advancement in multimodal imaging, tailored for researchers looking to enhance their imaging capabilities in spatial biology. The MIBIslide Blue...

Continue Reading
Win $1,500 for a Transformative First-Class Flight Experience

Updated Category News Views 129

Transform Your Travel with Upgraded Points' Contest Upgraded Points presents an exciting opportunity for travelers to experience the luxury of first-class flying without the usual financial burden. With the newly launched contest, one lucky winner will be awarded $1,500 to upgrade their domestic round-trip flight to first class and share their journey. This contest is...

Continue Reading
Invesque Inc.'s Q2 2025 Performance Reveals Strategic Changes

Updated Category News Views 96

Significant Progress in Asset Management Invesque Inc. (TSX: IVQ) recently shared promising results for the second quarter of 2025, showcasing significant achievements in asset management and strategic operations. Quarterly Highlights and Operations During this quarter, the company successfully executed several important asset sales: In April, Invesque concluded the sale...

Continue Reading
Goldman Sachs Confirms Buy Rating for CoStar Group's Growth Potential

Updated Category News Views 87

Goldman Sachs Supports CoStar Group with Buy Rating Goldman Sachs has reaffirmed its Buy rating for CoStar Group (NASDAQ: CSGP) and set a price target of $93.00. Recent analyses indicate that online traffic for CoStar's residential platform, Homes.com, has remained consistent, boosting growth expectations. In August, Homes.com attracted 35 million unique visitors, showing...

Continue Reading
LightPath Technologies Enhances Defense Capabilities with New LOI

Updated Category News Views 63

Strengthening Defense Partnerships in Optics LightPath Technologies, Inc. announces an exciting development in its commitment to enhancing optical systems for defense applications. The company has secured a Letter of Intent (LOI) for the sustained supply of infrared lens assemblies from an established European defense customer. This partnership not only represents a...

Continue Reading